Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Public ClinicalTrials.gov record NCT06609239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Extension Study to Evaluate the Long-term Safety and Efficacy of Subcutaneous Lunsekimig in Adult Participants With Asthma Who Participated in Study DRI16762 or ACT18301
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma who have previously completed the parent studies. After completion of the parent study, eligible participants will be offered the opportunity to participate in the long-term extension (LTE) study with lunsekimig. The study duration will be up to 148 weeks with a treatment duration being up to 144 weeks.
Study identification
- NCT ID
- NCT06609239
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 900 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2024
- Primary completion
- Jan 19, 2031
- Completion
- Jan 19, 2031
- Last update posted
- Aug 12, 2026
2024 – 2031
United States locations
- U.S. sites
- 29
- U.S. states
- 11
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Chandler Clinical Research Trials- Site Number : 8400075 | Chandler | Arizona | 85224 | — |
| Tucson Clinical Research Institute- Site Number : 8400085 | Tucson | Arizona | 85712 | — |
| Allianz Research Institute - Aurora- Site Number : 8400026 | Aurora | Colorado | 80014 | — |
| Western States Clinical Research- Site Number : 8400014 | Wheat Ridge | Colorado | 80033 | — |
| Helix Biomedics- Site Number : 8400114 | Boynton Beach | Florida | 33435 | — |
| Beautiful Minds Clinical Research Center- Site Number : 8400049 | Cutler Bay | Florida | 33157 | — |
| Qway Research - Hialeah- Site Number : 8400015 | Hialeah | Florida | 33010 | — |
| Clintex Research Group - Miami - Southwest 27th Avenue- Site Number : 8400048 | Miami | Florida | 33135 | — |
| High Quality Research- Site Number : 8400039 | Miami | Florida | 33184 | — |
| Innovations Biotech- Site Number : 8400040 | Miami | Florida | 33186 | — |
| New Access Medical Center- Site Number : 8400043 | Miami | Florida | 33186 | — |
| Deluxe Health Center- Site Number : 8400045 | Miami Lakes | Florida | 33014 | — |
| Tellabio International Research Services- Site Number : 8400083 | Pembroke Pines | Florida | 33025 | — |
| Avanza Medical Research Center- Site Number : 8400135 | Pensacola | Florida | 32503 | — |
| Ilumina Medical Research- Site Number : 8400095 | Saint Cloud | Florida | 34769 | — |
| Windom Allergy, Asthma and Sinus Specialists- Site Number : 8400019 | Sarasota | Florida | 34239 | — |
| Brigham & Women's Hospital- Site Number : 8400034 | Boston | Massachusetts | 02115 | — |
| University of Michigan Health System - Ann Arbor- Site Number : 8400004 | Ann Arbor | Michigan | 48109 | — |
| Midwest Clinical Research Center - St. Louis- Site Number : 8400006 | St Louis | Missouri | 63141 | — |
| Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400029 | Charlotte | North Carolina | 28287 | — |
| Asthma & Allergy Center - Toledo- Site Number : 8400017 | Toledo | Ohio | 43617 | — |
| OK Clinical Research- Site Number : 8400021 | Edmond | Oklahoma | 73034 | — |
| Clinical Research Associates of Central Pennsylvania- Site Number : 8400116 | DuBois | Pennsylvania | 15801 | — |
| Allergy & Clinical Immunology Associates Pittsburgh- Site Number : 8400007 | Pittsburgh | Pennsylvania | 15241 | — |
| Orion Clinical Research- Site Number : 8400001 | Austin | Texas | 78759 | — |
| South Texas Medical Research Institute - TTS Research- Site Number : 8400010 | Boerne | Texas | 78006 | — |
| Baylor University Medical Center- Site Number : 8400002 | Dallas | Texas | 75246 | — |
| Western Sky Medical Research- Site Number : 8400023 | El Paso | Texas | 79903 | — |
| Metroplex Pulmonary and Sleep Center- Site Number : 8400022 | McKinney | Texas | 75069 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06609239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06609239 live on ClinicalTrials.gov.